Progression of asthma measured by lung function in the childhood asthma management program.

From the Childhood Asthma Management Program cohort, which was randomly assigned to receive budesonide, nedocromil, or placebo for 4-6 years, we determined the prevalence of and factors associated with at least 1% per year loss in postbronchodilator FEV(1)% predicted. Participants who had a significant reduction in postbronchodilator FEV(1)% predicted (SRP), comprised 25.7% of the cohort (n = 990). Using logistic regression, predictors of SRP at baseline were younger age (p = 0.0005), male sex (p < 0.0001), clinic (p = 0.02), and higher postbronchodilator FEV(1)% predicted (p = 0.02). Examination of the SRPs indicated that the effect of baseline lung function was such that the higher the lung function, the less steep the reduction in postbronchodilator FEV(1)% predicted (p < 0.0001). A similar proportion of SRPs was found in each treatment group. Among the SRPs, the rate of reduction in postbronchodilator FEV(1)% predicted was similar in all treatment groups. At a single site where biomarker assessment was performed, SRPs also had more prominent eosinophilic inflammation during the washout period. The course and mechanisms of lung function reduction or slow lung growth velocity in children with asthma must be defined.

[1]  R. Wood,et al.  EARLY INTERVENTION WITH BUDESONIDE IN MILD PERSISTENT ASTHMA: A RANDOMIZED, DOUBLE-BLIND TRIAL , 2004, Pediatrics.

[2]  Phil A. Silva,et al.  A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. , 2003, The New England journal of medicine.

[3]  Richard J Martin,et al.  Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. , 2003, The Journal of pediatrics.

[4]  D. Judd.  Guidelines for the diagnosis and management of asthma: update on selected topics 2002. , 2003, Journal of the American Academy of Nurse Practitioners.

[5]  Marilyn Halonen,et al.  Tucson Children's Respiratory Study: 1980 to present. , 2003, The Journal of allergy and clinical immunology.

[6]  William W Busse,et al.  Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial , 2003, The Lancet.

[7]  A. Bush,et al.  Early thickening of the reticular basement membrane in children with difficult asthma. , 2003, American journal of respiratory and critical care medicine.

[8]  R. de Marco,et al.  Incidence and remission of asthma: a retrospective study on the natural history of asthma in Italy. , 2002, The Journal of allergy and clinical immunology.

[9]  D. Jacobs,et al.  Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. , 2002, American journal of respiratory and critical care medicine.

[10]  C. Rand,et al.  Environmental tobacco smoke exposure and nocturnal symptoms among inner-city children with asthma. , 2002, The Journal of allergy and clinical immunology.

[11]  F. Rasmussen,et al.  Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. , 2002, American journal of respiratory and critical care medicine.

[12]  D. Johns,et al.  Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma , 2002, Thorax.

[13]  A. Zwinderman,et al.  Factors associated with persistent airflow limitation in severe asthma. , 2001, American journal of respiratory and critical care medicine.

[14]  E. Israel,et al.  Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. , 2001, American journal of respiratory and critical care medicine.

[15]  J. Emerson,et al.  Effect of choice of reference equation on analysis of pulmonary function in cystic fibrosis patients * , 2001, Pediatric pulmonology.

[16]  P. Barnes,et al.  Neurogenic inflammation in the airways. , 2001, Respiration physiology.

[17]  J. Bousquet,et al.  Airway remodelling in the pathogenesis of asthma. , 2001, Current opinion in allergy and clinical immunology.

[18]  N Franklin Adkinson,et al.  Long-term effects of budesonide or nedocromil in children with asthma. , 2000, The New England journal of medicine.

[19]  J. Castro‐Rodriguez,et al.  A clinical index to define risk of asthma in young children with recurrent wheezing. , 2000, American journal of respiratory and critical care medicine.

[20]  D. Postma,et al.  Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. , 1999, American journal of respiratory and critical care medicine.

[21]  R. Zeiger,et al.  Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP) , 1999, The Journal of allergy and clinical immunology.

[22]  Heather Eliassen,et al.  The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. , 1999, Controlled clinical trials.

[23]  J Vestbo,et al.  A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.

[24]  W. Morgan,et al.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.

[25]  P. Lange,et al.  Decline of lung function in adults with bronchial asthma. , 1994, American journal of respiratory and critical care medicine.

[26]  J B Carlin,et al.  Factors in childhood as predictors of asthma in adult life , 1994, BMJ.

[27]  S. Pedersen,et al.  Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. , 1994, Respiratory medicine.

[28]  W. V. van Aalderen,et al.  Follow-up of asthma from childhood to adulthood: influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. , 1994, The Journal of allergy and clinical immunology.

[29]  M. Hughes,et al.  Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. , 1993, The American review of respiratory disease.

[30]  A. Dirksen,et al.  Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up. , 1992, The Journal of asthma : official journal of the Association for the Care of Asthma.

[31]  W. Morgan,et al.  The Tucson Children's Respiratory Study. I. Design and implementation of a prospective study of acute and chronic respiratory illness in children. , 1989, American journal of epidemiology.

[32]  J. Samet,et al.  Spirometric prediction equations for Hispanic children and adults in New Mexico. , 1988, The American review of respiratory disease.

[33]  A. Woolcock,et al.  Rate of decline of lung function in subjects with asthma. , 1987, European journal of respiratory diseases.

[34]  M. Lebowitz,et al.  Changes in the normal maximal expiratory flow-volume curve with growth and aging. , 1983, The American review of respiratory disease.

[35]  A. Afifi,et al.  Comparison of Stopping Rules in Forward “Stepwise” Regression , 1977 .